Brain Lower Grade Glioma: PARADIGM pathway analysis of mRNA expression data
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)
- Overview
+ Introduction
- Summary

There were 34 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
TCGA08_retinoblastoma 9
Ephrin A reverse signaling 8
FOXM1 transcription factor network 8
E-cadherin signaling events 7
IL23-mediated signaling events 6
PLK2 and PLK4 events 5
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 5
IL12-mediated signaling events 4
Endothelins 4
Signaling events mediated by the Hedgehog family 3
- Results

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
TCGA08_retinoblastoma 9 73 8 -0.15 0.15 1000 -1000 -0.018 -1000
Ephrin A reverse signaling 8 61 7 -0.22 0 1000 -1000 -0.007 -1000
FOXM1 transcription factor network 8 416 51 -1.1 0.017 1000 -1000 -0.14 -1000
E-cadherin signaling events 7 39 5 -0.24 0.017 1000 -1000 -0.012 -1000
IL23-mediated signaling events 6 369 60 -0.73 0.019 1000 -1000 -0.13 -1000
PLK2 and PLK4 events 5 16 3 -0.084 -1000 1000 -1000 -0.011 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 5 366 68 -0.63 0.39 1000 -1000 -0.093 -1000
IL12-mediated signaling events 4 367 87 -0.49 0.11 1000 -1000 -0.1 -1000
Endothelins 4 459 96 -0.36 0.039 1000 -1000 -0.054 -1000
Signaling events mediated by the Hedgehog family 3 177 52 -0.21 0.12 1000 -1000 -0.031 -1000
Thromboxane A2 receptor signaling 3 385 105 -0.32 0.07 1000 -1000 -0.057 -1000
HIF-1-alpha transcription factor network 3 290 76 -0.23 0.04 1000 -1000 -0.059 -1000
PDGFR-alpha signaling pathway 3 163 44 -0.35 0.034 1000 -1000 -0.058 -1000
Nongenotropic Androgen signaling 3 165 52 -0.23 0.12 1000 -1000 -0.047 -1000
Signaling events mediated by VEGFR1 and VEGFR2 3 459 125 -0.18 0.03 1000 -1000 -0.079 -1000
Stabilization and expansion of the E-cadherin adherens junction 3 268 74 -0.24 0.12 1000 -1000 -0.072 -1000
E-cadherin signaling in the nascent adherens junction 3 233 76 -0.24 0.025 1000 -1000 -0.072 -1000
Aurora B signaling 3 212 67 -0.27 0.017 1000 -1000 -0.064 -1000
Syndecan-1-mediated signaling events 2 81 34 -0.31 0.017 1000 -1000 -0.032 -1000
Visual signal transduction: Cones 2 99 38 -0.11 0.025 1000 -1000 -0.014 -1000
Osteopontin-mediated events 2 82 38 -0.19 0.017 1000 -1000 -0.081 -1000
Arf6 signaling events 2 157 62 -0.15 0.027 1000 -1000 -0.018 -1000
Fc-epsilon receptor I signaling in mast cells 2 227 97 -0.19 0.043 1000 -1000 -0.071 -1000
PLK1 signaling events 2 243 85 -0.24 0.025 1000 -1000 -0.04 -1000
IL1-mediated signaling events 2 162 62 -0.22 0.071 1000 -1000 -0.074 -1000
Ephrin B reverse signaling 2 132 48 -0.15 0.12 1000 -1000 -0.055 -1000
S1P1 pathway 2 83 36 -0.15 0.017 1000 -1000 -0.057 -1000
TCGA08_p53 2 19 7 -0.12 0.077 1000 -1000 -0.011 -1000
Effects of Botulinum toxin 2 66 26 -0.26 0.017 1000 -1000 -0.054 -1000
Calcium signaling in the CD4+ TCR pathway 2 85 31 -0.19 0.026 1000 -1000 -0.054 -1000
IL6-mediated signaling events 2 186 75 -0.19 0.068 1000 -1000 -0.057 -1000
BCR signaling pathway 2 204 99 -0.14 0.03 1000 -1000 -0.073 -1000
Syndecan-4-mediated signaling events 2 176 67 -0.18 0.035 1000 -1000 -0.037 -1000
Rapid glucocorticoid signaling 2 40 20 -0.22 0.017 1000 -1000 -0.01 -1000
LPA4-mediated signaling events 1 14 12 -0.081 0.022 1000 -1000 -0.012 -1000
Caspase cascade in apoptosis 1 87 74 -0.1 0.028 1000 -1000 -0.028 -1000
Regulation of nuclear SMAD2/3 signaling 1 231 136 -0.41 0.11 1000 -1000 -0.046 -1000
Coregulation of Androgen receptor activity 1 124 76 -0.2 0.037 1000 -1000 -0.027 -1000
ErbB4 signaling events 1 96 69 -0.23 0.072 1000 -1000 -0.079 -1000
BARD1 signaling events 1 62 57 -0.13 0.034 1000 -1000 -0.034 -1000
Sphingosine 1-phosphate (S1P) pathway 1 38 28 -0.084 0.025 1000 -1000 -0.014 -1000
Circadian rhythm pathway 1 23 22 -0.15 0.04 1000 -1000 -0.029 -1000
Noncanonical Wnt signaling pathway 1 33 26 -0.084 0.02 1000 -1000 -0.031 -1000
Syndecan-2-mediated signaling events 1 84 69 -0.14 0.04 1000 -1000 -0.021 -1000
a4b1 and a4b7 Integrin signaling 1 9 5 -0.034 0.017 1000 -1000 -0.011 -1000
Cellular roles of Anthrax toxin 1 77 39 -0.24 0.018 1000 -1000 -0.021 -1000
Presenilin action in Notch and Wnt signaling 1 93 61 -0.3 0.043 1000 -1000 -0.06 -1000
Aurora A signaling 1 108 60 -0.17 0.051 1000 -1000 -0.02 -1000
p75(NTR)-mediated signaling 1 192 125 -0.31 0.043 1000 -1000 -0.07 -1000
IL4-mediated signaling events 1 122 91 -0.52 0.26 1000 -1000 -0.13 -1000
BMP receptor signaling 1 159 81 -0.17 0.039 1000 -1000 -0.074 -1000
Glypican 1 network 1 54 48 -0.11 0.032 1000 -1000 -0.026 -1000
amb2 Integrin signaling 1 148 82 -0.14 0.023 1000 -1000 -0.065 -1000
Nectin adhesion pathway 1 103 63 -0.24 0.026 1000 -1000 -0.061 -1000
Glucocorticoid receptor regulatory network 1 138 114 -0.31 0.069 1000 -1000 -0.058 -1000
Paxillin-independent events mediated by a4b1 and a4b7 1 66 37 -0.31 0.025 1000 -1000 -0.026 -1000
TRAIL signaling pathway 1 52 48 -0.026 0.035 1000 -1000 -0.062 -1000
Signaling events regulated by Ret tyrosine kinase 1 156 82 -0.17 0.017 1000 -1000 -0.079 -1000
RXR and RAR heterodimerization with other nuclear receptor 1 58 52 -0.27 0.05 1000 -1000 -0.046 -1000
FAS signaling pathway (CD95) 1 55 47 -0.11 0.047 1000 -1000 -0.031 -1000
Signaling mediated by p38-gamma and p38-delta 1 16 15 -0.12 0.03 1000 -1000 -0.014 -1000
Paxillin-dependent events mediated by a4b1 1 43 36 -0.31 0.034 1000 -1000 -0.071 -1000
Syndecan-3-mediated signaling events 1 51 35 -0.14 0.043 1000 -1000 -0.03 -1000
Signaling mediated by p38-alpha and p38-beta 1 77 44 -0.1 0.017 1000 -1000 -0.027 -1000
Integrins in angiogenesis 1 154 84 -0.16 0.031 1000 -1000 -0.076 -1000
TCR signaling in naïve CD8+ T cells 1 112 93 -0.12 0.028 1000 -1000 -0.063 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 1 61 45 -0.1 0.017 1000 -1000 -0.07 -1000
Canonical Wnt signaling pathway 1 68 51 -0.3 0.14 1000 -1000 -0.033 -1000
EPHB forward signaling 1 90 85 -0.15 0.06 1000 -1000 -0.08 -1000
Glypican 2 network 1 6 4 -0.012 0 1000 -1000 -0.007 -1000
IL27-mediated signaling events 1 53 51 -0.19 0.025 1000 -1000 -0.079 -1000
Wnt signaling 1 12 7 -0.084 0.017 1000 -1000 -0.016 -1000
LPA receptor mediated events 1 119 102 -0.19 0.036 1000 -1000 -0.063 -1000
IL2 signaling events mediated by STAT5 1 36 22 -0.18 0.078 1000 -1000 -0.033 -1000
EGFR-dependent Endothelin signaling events 1 36 21 -0.099 0.025 1000 -1000 -0.064 -1000
Angiopoietin receptor Tie2-mediated signaling 1 142 88 -0.19 0.026 1000 -1000 -0.093 -1000
Neurotrophic factor-mediated Trk receptor signaling 1 156 120 -0.28 0.13 1000 -1000 -0.068 -1000
Visual signal transduction: Rods 1 100 52 -0.11 0.017 1000 -1000 -0.074 -1000
Signaling events mediated by PRL 1 67 34 -0.14 0.025 1000 -1000 -0.026 -1000
E-cadherin signaling in keratinocytes 1 81 43 -0.24 0.05 1000 -1000 -0.033 -1000
Class IB PI3K non-lipid kinase events 1 3 3 -0.002 0.002 1000 -1000 -0.006 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 1 138 78 -0.11 0.076 1000 -1000 -0.055 -1000
Ras signaling in the CD4+ TCR pathway 1 33 17 -0.072 0.021 1000 -1000 -0.02 -1000
ErbB2/ErbB3 signaling events 0 62 65 -0.1 0.026 1000 -1000 -0.051 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0 8 23 -0.012 0.034 1000 -1000 -0.034 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0 1 34 -0.026 0.053 1000 -1000 -0.017 -1000
Canonical NF-kappaB pathway 0 28 39 -0.1 0.082 1000 -1000 -0.067 -1000
Signaling events mediated by HDAC Class II 0 33 75 -0.085 0.041 1000 -1000 -0.034 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0 28 54 -0.071 0.032 1000 -1000 -0.085 -1000
JNK signaling in the CD4+ TCR pathway 0 8 17 -0.019 0.034 1000 -1000 -0.031 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0 60 85 -0.19 0.049 1000 -1000 -0.059 -1000
Signaling events mediated by PTP1B 0 60 76 -0.1 0.034 1000 -1000 -0.062 -1000
Hedgehog signaling events mediated by Gli proteins 0 58 65 -0.048 0.043 1000 -1000 -0.049 -1000
Arf6 downstream pathway 0 12 43 -0.027 0.032 1000 -1000 -0.031 -1000
Aurora C signaling 0 3 7 -0.012 0.002 1000 -1000 -0.026 -1000
FOXA2 and FOXA3 transcription factor networks 0 17 46 -0.038 0.1 1000 -1000 -0.041 -1000
EPO signaling pathway 0 17 55 -0.049 0.052 1000 -1000 -0.073 -1000
Insulin-mediated glucose transport 0 13 32 -0.014 0.047 1000 -1000 -0.025 -1000
mTOR signaling pathway 0 11 53 -0.017 0.049 1000 -1000 -0.055 -1000
IFN-gamma pathway 0 56 68 -0.1 0.069 1000 -1000 -0.076 -1000
Class I PI3K signaling events mediated by Akt 0 18 68 -0.071 0.066 1000 -1000 -0.053 -1000
Ceramide signaling pathway 0 67 76 -0.1 0.025 1000 -1000 -0.026 -1000
Signaling events mediated by HDAC Class III 0 28 40 -0.19 0.097 1000 -1000 -0.022 -1000
Reelin signaling pathway 0 45 56 -0.11 0.038 1000 -1000 -0.064 -1000
S1P5 pathway 0 7 17 -0.02 0.025 1000 -1000 -0.012 -1000
ceramide signaling pathway 0 34 49 -0.099 0.025 1000 -1000 -0.026 -1000
HIF-2-alpha transcription factor network 0 28 43 -0.16 0.12 1000 -1000 -0.053 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0 68 83 -0.087 0.05 1000 -1000 -0.061 -1000
Signaling events mediated by HDAC Class I 0 63 104 -0.1 0.052 1000 -1000 -0.052 -1000
FoxO family signaling 0 21 64 -0.051 0.1 1000 -1000 -0.06 -1000
Retinoic acid receptors-mediated signaling 0 36 58 -0.12 0.063 1000 -1000 -0.071 -1000
Atypical NF-kappaB pathway 0 7 31 -0.056 0.038 1000 -1000 -0.022 -1000
IL2 signaling events mediated by PI3K 0 38 58 -0.048 0.066 1000 -1000 -0.065 -1000
Regulation of p38-alpha and p38-beta 0 39 54 -0.084 0.043 1000 -1000 -0.05 -1000
TCGA08_rtk_signaling 0 20 26 -0.092 0.035 1000 -1000 -0.017 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0 3 27 -0.008 0.043 1000 -1000 -0.044 -1000
Class I PI3K signaling events 0 64 73 -0.12 0.037 1000 -1000 -0.045 -1000
Arf6 trafficking events 0 32 71 -0.11 0.066 1000 -1000 -0.053 -1000
Regulation of Telomerase 0 100 102 -0.19 0.049 1000 -1000 -0.091 -1000
IGF1 pathway 0 37 57 -0.07 0.051 1000 -1000 -0.087 -1000
Insulin Pathway 0 38 74 -0.11 0.054 1000 -1000 -0.078 -1000
Plasma membrane estrogen receptor signaling 0 56 86 -0.063 0.056 1000 -1000 -0.069 -1000
VEGFR1 specific signals 0 19 56 -0.07 0.048 1000 -1000 -0.037 -1000
S1P3 pathway 0 23 42 -0.063 0.051 1000 -1000 -0.025 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0 21 33 -0.16 0.05 1000 -1000 -0.02 -1000
PDGFR-beta signaling pathway 0 78 97 -0.092 0.044 1000 -1000 -0.072 -1000
S1P4 pathway 0 4 25 -0.005 0.032 1000 -1000 -0.015 -1000
p38 MAPK signaling pathway 0 43 44 -0.12 0.033 1000 -1000 -0.06 -1000
Arf1 pathway 0 2 54 -0.004 0.037 1000 -1000 -0.03 -1000
Alternative NF-kappaB pathway 0 7 13 -0.005 0.031 1000 -1000 -0.013 -1000
Regulation of Androgen receptor activity 0 61 70 -0.31 0.073 1000 -1000 -0.052 -1000
Total 164 12178 7203 -22 -990 131000 -131000 -6.4 -131000
+ Methods & Data